UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002046
Receipt number R000002153
Scientific Title Metabolic Syndrome Regulates the Non-Elderly or Non-Stenotic Onset in Patients with Acute Myocardial Infarction (Retrospective MAMI Study)
Date of disclosure of the study information 2009/06/08
Last modified on 2009/11/23 11:54:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Metabolic Syndrome Regulates the Non-Elderly or Non-Stenotic Onset in Patients with Acute Myocardial Infarction (Retrospective MAMI Study)

Acronym

MetS Regulates the Onset Form of AMI.(Retrospective MAMI Study)

Scientific Title

Metabolic Syndrome Regulates the Non-Elderly or Non-Stenotic Onset in Patients with Acute Myocardial Infarction (Retrospective MAMI Study)

Scientific Title:Acronym

MetS Regulates the Onset Form of AMI.(Retrospective MAMI Study)

Region

Japan


Condition

Condition

acute myocardial infarction

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the role of metabolic syndrome as a regulator of early onset or non-stenotic onset in acute myocardial infarction.

Basic objectives2

Others

Basic objectives -Others

To know the way of prevention against acute myocardial infarction

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The relationship between metabolic syndrome and early or non-stenotic type onset in acute myocardial infarction

Key secondary outcomes

The influence of the following other risk factors on the early or non-stenotic type onset in acute myocardial infarction; smoking, hypertension, high TC, high TG, low HDL-C, gender, HOMA index, number of diseased vessels.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

95 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Patients who sustained acute myocardial infarction and received usual treatment in the Division of Cardiovascular Medicine, Oita University Hospital between January 2002 and December 2006.
(2)Patients who sustained acute myocardial infarction and received usual treatment in the Cardiovascular Division in the following hospitals between January 2002 and December 2006; Oita Medical Center,Health Insurance Nankai Hospital, Oita Red Cross Hospital, and Beppu Medical Center.
(3)Patients without myocardial infarction who entered the Division of Cardiovascular Medicine of Oita University Hospital for cardiac catheterization between January 2005 and December 2008.

Key exclusion criteria

Patients who did not undergo emergency coronary angiography or those who had a history of myocardial infarction.

Target sample size

430


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahide Hara

Organization

Oita University

Division name

Division of Cardiovascular Medicine

Zip code


Address

1-chome, 1-banchi, Idai-ga-oka, Hasama-machi, Yufu City, Oita

TEL

097-586-5791

Email



Public contact

Name of contact person

1st name
Middle name
Last name Masahide Hara

Organization

Oita University

Division name

Division of Cardiovascular Medicine

Zip code


Address

1-chome, 1-banchi, Idai-ga-oka, Hasama-machi, Yufu City, Oita

TEL

097-586-5791

Homepage URL

http://www.med.oita-u.ac.jp/junkanki/

Email

m-hara@med.oita-u.ac.jp


Sponsor or person

Institute

Division of Cardiovascular Medicine, Oita University

Institute

Department

Personal name



Funding Source

Organization

Division of Cardiovascular Medicine, Oita University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 06 Month 08 Day


Related information

URL releasing protocol

http://www.med.oita-u.ac.jp/junkanki/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 06 Month 05 Day

Date of IRB


Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2009 Year 06 Month 01 Day

Date of closure to data entry

2009 Year 06 Month 01 Day

Date trial data considered complete

2009 Year 06 Month 01 Day

Date analysis concluded

2009 Year 06 Month 01 Day


Other

Other related information

According to the clinical records, we collect following data regarding time from onset, infarct-related artery, receiving of emergency coronary angiography, operation of reperfusion therapy, reperfusion success, occurrence of slow flow phenomenon, operation of emergency coronary artery bypass grafting, serum concentration of the max creatine kinase, left ventricular ejection fraction, and in-hospital death. And the incidence of risk factors such as smoking, hypercholesterolemia, hypertriglyceridemia, low HDL-cholesterolemia, impaired glucose tolerance or diabetes, metabolic syndrome, and hypertension are also analyzed. We additionally analyze the angiographic data such as coronary occlusive form and the number of diseased vessel. We compare the background risk factors and angiographic data among the four groups (non-elderly, young-elderly, old-elderly, and the control) using univariate analysis. We divide the study patients into the non-elderly onset group and the other groups (young-elderly, old-elderly, and the control). Similarly, the patients with acute myocardial infarction are classified into the stenotic and the non-stenotic occlusion group. To clarify the regulating factors of non-elderly or non-stenotic onset of acute myocardial infarction we analyze the data using multivariate analysis.


Management information

Registered date

2009 Year 06 Month 04 Day

Last modified on

2009 Year 11 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002153


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name